• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 AVITENE; AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 AVITENE; AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED Back to Search Results
Catalog Number 1020010
Medical Device Problem Code Tear, Rip or Hole in Device Packaging (2385)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/31/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
As reported, during set up small holes were noted in the packaging of an avitene flowable.Evaluation of the returned sample confirmed that there is no sterile barrier breach.Although multiple visual observations were noted during the evaluation, all observations, including foil creasing, were considered to be from normal handling and pouch opening.All the observations were dye tested using astm f3039 as guidance.There were zero breaches of the material found during this testing.No manufacturing anomalies were found.A review of the manufacturing records was performed and found that the lot was manufactured to the specification.This emdr represents the avitene flowable (device 1).An additional emdr was submitted to represent the avitene flowable (device 2).Note: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
As reported, during set up of a laminectomy procedure, upon opening the foil pouch of the avitene flowable, wrinkling of the foil pouch was observed, and small holes were noted at the wrinkled areas.There was no damage noted to the outer packaging.This file represents device #1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVITENE
Common Device Name
AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
DAVOL INC. -1223089
160 new boston st.
woburn MA 01801
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key24983586
Report Number1213643-2026-00561
Device Sequence Number15863760
Product Code LMF
UDI-Device Identifier00801741223105
UDI-Public(01)00801741223105
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
N17600
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number1020010
Device Lot NumberWBKT0041
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/10/2026
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/31/2026
Supplement Date Received by Manufacturer04/28/2026
Initial Report FDA Received Date04/24/2026
Supplement Report FDA Received Date05/07/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/03/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-